By Marta Figueiredo PhD | November 18, 2021 Recent findings and ongoing efforts to more fully understand the underlying molecular mechanisms of amyotrophic lateral sclerosis (ALS), and to identify new and better ways of helping patients were discussed at the 11th Annual Les Turner Symposium …
Faces of ALS: Air Force Veteran Lori Hoover
Lori’s Story: Aim High…Fly-Fight-Win! Every November on Veterans Day, we honor and remember the veterans who served our country in the Armed Forces. Due to the strong connection between military service and ALS, the Foundation also remembers and honors those …
November 2021 Foundation eNews
Amylyx Pharmaceuticals Has Submitted a New Drug Application to the FDA for AMX0035 to Treat ALS Amylyx Pharmaceuticals today announced it has submitted a New Drug Application (NDA) to the FDA for AMX0035 for the treatment of ALS. This New …
November 2021 Events eNews
Special Feature on Support Groups As November is National Family Caregivers Month, this edition of ALS Event News focuses on support groups for people living with ALS and their families. The Les Turner ALS Foundation has long offered comforting …
Les Turner ALS Symposium Celebrates Advances in Research and Patient Care
BY MELISSA ROHMAN ON NOV 4, 2021 Northwestern scientists and clinicians demonstrated their continued commitment to advancing knowledge and therapies for amyotrophic lateral sclerosis (ALS) during the 11th annual Les Turner Symposium on ALS. The virtual, daylong symposium featured scientific presentations highlighting the molecular …
